7,161 followers
@leochacon
@leochacon
RT @SCCM_CPP: #CPPPLU Highlights. This recent trial from @CritCareMed found a 22.4% ↑ mortality in patients treated with meropenem compared…
RT @SCCM_CPP: #CPPPLU Highlights. This recent trial from @CritCareMed found a 22.4% ↑ mortality in patients treated with meropenem compared…
#CPPPLU Highlights. This recent trial from @CritCareMed found a 22.4% ↑ mortality in patients treated with meropenem compared to ceftolozane/tazobactam who previously failed antibacterial therapy for HABP/VABP. #PharmICU https://t.co/nPZdGDZIpC https://t.c